PFE

SELL

Pfizer, Inc.

Healthcare · Rank #351 · Analyzed Apr 20, 2026

$27.56

Current Price

$34.33

Intrinsic Value

+102.3%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 102.3%

Fair Value Range

Low$12.20

Base (IV)$34.33

High$55.76

Entry Points

Conservative$12.20

Moderate$23.27

Aggressive$34.33

Quality & Moat Breakdown

Return on Equity8.9% → 0/1.0

Debt LevelD/E 78 → 0/1.0

Revenue QualityGrowth -11.0%, margin Δ+40.2% +recovery → 0.5/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins12.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.